Alzamend Neuro, Inc. ALZN

1.83 0.01 0.55% as of 25 Sep

Follow ALZN

Insider Buys alert about insiders buying in the last 12 month

	Older periods	Oct '25	Jan '26	Apr '26	Jul '26
ROE Full definition →	+8 more TTM periods Free account	(157.96%)	(267.82%)	(373.18%)	(163.23%)
ROA Full definition →		(127.12%)	(183.63%)	(262.55%)	(122.36%)
ROIC Full definition →		0.00%	0.00%	(24,352.50%)	0.00%
Return on Tangible Assets Full definition →		(146.75%)	(345.36%)	(1,196.45%)	(156.77%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(1.67)	(1.57)	(2.42)	(1.53)
Free Cash Flow Full definition →		(5.65)	(5.96)	(8.07)	(6.84)
Other line items
Cash ROIC Full definition →		(63.99%)	(121.68%)	(558.75%)	(51.09%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Interest Coverage Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		0.88	0.79	0.92	0.75
Depreciation/Fixed assets Full definition →		0.22	0.28	0.35	0.39
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(1.67)	(1.57)	(2.42)	(1.53)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Net Profit Margin Full definition →		0.00%	0.00%	0.00%	0.00%

Columns are period end dates

Powerpack